BIOLASE (BIOL) Will Showcase OCCULASE Via New, Dedicated Website

January 23, 2013 8:35 AM EST
BIOLASE, Inc. (Nasdaq: BIOL) has launched a website to showcase OCCULASE, a wholly-owned subsidiary of BIOLASE, dedicated to expanding the multiple applications of its proprietary WaterLase technology and other related intellectual property into ophthalmology.

OCCULASE, under the direction of BIOLASE, is currently performing proof of concept research and clinical studies with the assistance of various ophthalmic specialists under the supervision of Dan Durrie, its Chief Ophthalmology Advisor.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment